CreditReports.dk
HomeScreen companies

BASE life science A/S Financials, key figures and credit report

CVR number: 30906942 Established 2007 Industry: 70 Activities of head offices and management consultancy
Company contact details
Lyngbyvej 2, 2100 København Ø contact@baselifescience.com tel: 88202120 www.baselifescience.com
Gross profit 235 554.7 kDKK FY 2024 -0.5% vs 2023
EBIT -45 276.4 kDKK FY 2024 +44.9% vs 2023
Net debt -28 744.2 kDKK FY 2024 -133% vs 2023
Quick ratio 1.9 FY 2024 +0.6 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit110 194.51158 135.50202 294.94236 774.34235 554.66
Employee benefit expenses-89 329.66- 125 405.77- 223 849.71- 315 093.35- 277 834.77
Total depreciation- 138.38- 914.79-2 900.36-3 784.75-2 996.34
EBIT20 726.4731 814.93-24 455.13-82 103.76-45 276.45
Other financial income26.51113.71171.043 158.732 197.65
Other financial expenses- 277.90- 460.66- 722.70-6 849.83-8 728.56
Pre-tax profit20 475.0931 467.98-25 006.79-85 794.86-51 807.35
Income taxes-3 198.04-7 273.18-6 217.50-2 512.27- 351.17
Net earnings17 277.0524 194.81-31 224.29-88 307.13-52 158.52

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure4 123.264 839.423 859.752 894.811 929.88
Intangible rights83.0765.2747.47
Intangible assets total4 123.264 839.423 942.822 960.081 977.34
Machinery and equipment470.343 097.713 999.053 118.107 296.41
Tangible assets total470.343 097.713 999.053 118.107 296.41
Investments total468.92925.201 051.811 689.262 164.41
Long term receivables total
Inventories total
Current trade debtors33 474.7872 812.5841 975.3859 841.2135 075.56
Current owed by particip. interest comp.1 284.337 838.288 850.85
Prepayments and accrued income409.694 135.832 571.554 205.232 515.58
Current other receivables8 173.2810 797.6652 603.7454 618.1333 950.11
Current deferred tax assets921.392 482.461 362.17
Short term receivables total42 979.1487 746.0798 434.99128 985.3181 754.26
Cash and bank deposits9 347.613 676.3112 229.0118 681.4879 111.68
Cash and cash equivalents9 347.613 676.3112 229.0118 681.4879 111.68
Balance sheet total (assets)57 389.26100 284.71119 657.68155 434.23172 304.10

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital600.00600.00597.40597.40600.40
Share premium account164 123.00
Shares repurchased2 109.00
Other reserves4 123.263 763.263 010.612 257.951 505.30
Retained earnings4 804.8021 657.2049 112.5118 853.17-68 489.02
Profit of the financial year17 277.0524 194.81-31 224.29-88 307.13-52 158.52
Shareholders equity total28 914.1050 215.2721 496.23-66 598.6145 581.16
Provisions1 250.001 265.27997.93802.66395.14
Non-current loans from credit institutions1 923.29
Non-current owed to group member97 379.5436 819.54
Non-current liabilities total1 923.2997 379.5436 819.54
Current loans from credit institutions110.683 063.09347.65558.51503.57
Advances received256.35947.682 407.567 817.503 223.32
Current trade creditors2 041.219 027.603 895.989 372.694 392.98
Current owed to participating513.06513.06
Current owed to group member1 254.017 959.7813 044.34
Short-term deferred tax liabilities3 451.769 089.4810 468.093 147.661 767.05
Other non-interest bearing current liabilities16 743.4026 163.2778 790.2394 994.4966 577.01
Accruals and deferred income2 185.41
Current liabilities total25 301.8748 804.1897 163.52123 850.6489 508.26
Balance sheet total (liabilities)57 389.26100 284.71119 657.68155 434.23172 304.10
Page generated